We are pleased to announce and welcome Alan Belicha to the Chameleon team as Vice President of Business Development.
In this role, Alan will guide Chameleon’s corporate development and partnering strategy, and contribute to financing efforts. We are excited to have Alan’s experience from the University of Buffalo, Mount Sinai Innovation Partners, and TTO Consulting Strategic available to our team, and are looking forward to expanding the reach of our EVADER™ technology through partnerships with pharma, biotech, and academic organizations.
Alan earned a Ph.D. in molecular tumor immunology at Roswell Park Cancer Institute and completed a postdoctoral fellowship at the Icahn School of Medicine at Mount Sinai in New York City.